| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Fels Research Institute and Department of Microbiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 [N. Y., S. F.], and Division of Biology, Southwest Center for Advanced Sciences, Dallas, Texas 75230 [H. T.]
4-Nitroquinoline 1-oxide (4NQO)-sensitive mutants of Salmonella typhimurium were found to be sensitive to ultraviolet light (UV) and ß-propiolactone. These mutants were subdivided into two groups: host cell reactivation minus (hc
) mutants lacking repair activity for the UV-damaged superinfecting phage and recombination-deficient (rec-) mutants. The hc
mutant is known to lack an enzyme to excise pyrimidine dimers formed in UV-irradiated DNA.
4NQO, ß-propiolactone, and UV induced prophages from hc
and wild-type strains but not from re
strains. Prophage induction from hc
strains was far more efficient than that from wild-type strain.
A metabolic intermediate of 4NQO, 4-hydroxylamino-quinoline 1-oxide (4HAQO), which is highly carcinogenic, inactivated Salmonella phage P22 in vitro whereas 4NQO did not. When 4HAQO-treated P22 was assayed simultaneously on hc
, re
, and wild-type strains lysogenic for P221b, no difference in inactivation rates on these indicator hosts was found. This indicates that the 4HAQO-damaged phage genome is not repairable by the hosts. Moreover, although a greatly increased frequency of recombination was found between the 4HAQO-treated P22 and the prophage P221b in wild-type and hc
hosts, no significant increase of recombination was found in re
strains. Thus, it was concluded that the bacterial recombination mechanism plays an important role in recombination between the damaged P22 and the prophage P221b.
1 Supported in part by NIH Grants AI-06429 and CA-10439, USPHS, and National Science Foundation Grant NSF-GB-8503. The work carried out in Dallas (by H. T.) was supported by USPHS Grant NIH-AI-06971 (awarded to Dr. J. Jagger).
2 Present address: Department of Fundamental Radiology, Faculty of Medicine, Osaka University Kita-ku, Osaka 530, Japan.
Received 2/11/70. Accepted 6/22/70.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |